BioAge Labs BIOA 深 滬
已收盤 08-07 16:00:00 美东时间
11.72
+0.450
+3.99%
華盛通- 最 高11.94
- 今 開11.40
- 成交量 95.33万股
- 最 低 11.2286
- 昨 收 11.27
- 總市值 5.21亿
- 52周最高 25.955
- 市盈率 靜 --
- 換手率 2.14%
- 52周最低 4.38
- 委 比 -70.92%
- 總股本 4445.27万
- 歷史最高 26.62
- 量 比 0.27
- 振 幅 6.31%
- 歷史最低 0.156
- 每 手 1
- 風險率 6.50%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bioage Labs Q2 EPS $(0.58) Beats $(0.60) Estimate, Sales $2.451M Beat $1.920M Estimate
Bioage Labs (NASDAQ:BIOA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.60) by 3.33 percent. This is a 3.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $2.451 million which...
08-06 05:19
美股牛股 | Atkore飙升逾28%，获电缆巨头大幅溢价收购！CoreWeave劲升近20%，新获木头姐增持29.8万股
Atkore飙升逾28%，获电缆巨头大幅溢价收购！CoreWeave劲升近20%，新获木头姐增持29.8万股；AAOI升逾16%，英伟达官宣CPO步入量产提振板块>>
08-04 19:06
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
美股大行评级 | 最高400美元！亚马逊绩后获11家大行上调目标价；苹果绩后评级分歧大！3家上调，3家下调；德康医疗、万事达、神经分泌生物科学获多家大行上调目标价
今日重点评级关注：TD Cowen：维持加拿大鹅"买入"评级，目标价从13美元升至18美元；瑞银：维持吉登运动服"买入"评级，目标价从110美元升至111美元
08-03 11:38
Why Is BioAge Labs Stock Sinking Friday?
BioAge Labs Inc. (NASDAQ:BIOA) stock plunged Friday after disappointing Phase 3 cardiovascular trial results from Novo Nordisk A/S (NYSE:NVO) sparked concerns about the potential of NLRP3-targeting therapies. William Blair analyst Andy Hsieh said the results from Novo Nordisk’s ZEUS trial cast doubt...
08-01 01:24
BioAge Labs shares are trading lower amid possible sympathy with Novo Nordisk after its ZEUS phase 3 trial did not translate into a MACE risk reduction.
BioAge Labs shares are trading lower amid possible sympathy with Novo Nordisk after its ZEUS phase 3 trial did not translate into a MACE risk reduction.
08-01 00:20
Oppenheimer’s ‘best of the best’ momentum list: NVDA, LRCX and more
Nvidia (NVDA) and Lam Research (LRCX) are among the largest names on Oppenheimer’s latest “best of the best” momentum screen. Oppenheimer’s technical analysis team said the list provides technical col...
07-20 03:10
美股大行评级 | 潜在涨幅99.91%！Tigress Financial上调英伟达目标价至425美元，维持"强力买入"评级
今日重点评级关注：Tigress Financial：维持英伟达"强力买入"评级，目标价从360美元升至425美元；康托·菲茨杰拉德：维持DeFi Development"超配"评级，目标价从6美元升至7美元
05-28 19:00
Roth Capital Initiates Coverage On Bioage Labs with Buy Rating, Announces Price Target of $36
Roth Capital analyst Adam Walsh initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Buy rating and announces Price Target of $36.
05-27 18:08
